Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Nature Genetics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ng1282PMID 14702042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dissecting p53 tumor suppressor functions in vivo.

  2002cited by this paper
• Loss of p53 and centrosome hyperamplification

  2002cited by this paper
• Ataxia Telangiectasia Mutated-Dependent Apoptosis after Genotoxic Stress in the Developing Nervous System Is Determined by Cellular Differentiation Status

  2001cited by this paper
• Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway

  2001cited by this paper
• Surfing the p53 network

  2000cited by this paper
• High metastatic potential in mice inheriting a targeted p53 missense mutation.

  2000cited by this paper
• Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.

  1999cited by this paper
• Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

  1998cited by this paper
• Functional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation

  1998cited by this paper
• V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.

  1998cited by this paper
• No Requirement for V(D)J Recombination in p53-Deficient Thymic Lymphoma

  1998cited by this paper
• Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation.

  1998cited by this paper
• Genetic instability in animal tumorigenesis models.

  1997cited by this paper
• Genetic instability in animal tumorigenesis models.

  1997cited by this paper
• Genetic instability in colorectal cancers

  1997cited by this paper
• Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53

  1997cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Cancer-susceptibility genes. Gatekeepers and caretakers.

  1997cited by this paper
• Specific loss of apoptotic but not cell‐cycle arrest function in a human tumor derived p53 mutant.

  1996cited by this paper
• Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function

  1996cited by this paper
• p53: puzzle and paradigm.

  1996cited by this paper
• Regulation of genomic instability in preneoplastic cells.

  1996cited by this paper
• Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.

  1994cited by this paper
• p53-dependent apoptosis suppresses tumor growth and progression in vivo.

  1994cited by this paper
• Tumor spectrum analysis in p53-mutant mice.

  1994cited by this paper
• p53 is required for radiation-induced apoptosis in mouse thymocytes

  1993cited by this paper
• In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Thymocyte apoptosis induced by p53-dependent and independent pathways

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Targeted oncogene activation by site-specific recombination in transgenic mice.

  1992cited by this paper

• A systematic analysis of the network of lncRNAs and mRNAs regulated by TP53 and TP53 mutants with hotspot mutations

  2025cites this paper
• The TP53 tumor suppressor gene: From molecular biology to clinical investigations

  2025cites this paper
• Specific TP53 mutations impair the recruitment of 53BP1 to DNA double-strand breaks underlying the mechanism of radioresistance

  2025cites this paper
• Comprehensive computational analysis via Adverse Outcome Pathways and Aggregate Exposure Pathways in exploring synergistic effects from radon and tobacco smoke on lung cancer

  2025cites this paper
• Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma–GATA3 molecular subgroup

  2025cites this paper
• Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations

  2025cites this paper
• Mis-splicing drives loss of function of p53E224D point mutation

  2025cites this paper
• Targeted Degradation of Mutant p53 Reverses the Pro-oncogenic Dominant-Negative Effect.

  2025cites this paper
• Hypoxia inducible factor 1α-driven steroidogenesis impacts systemic hematopoiesis

  2025cites this paper
• Mutant p53 Gain-of-Function in the Spotlight: Are We Suffering a GOF Delusion?

  2024cites this paper
• Cancerous time estimation for interpreting the evolution of lung adenocarcinoma

  2024cites this paper
• Understanding the complexity of p53 in a new era of tumor suppression.

  2024cites this paper
• Splicing DNA Damage Adaptations for the Management of Cancer Cells.

  2024cites this paper
• Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC

  2024cites this paper
• Arachidonoylethanolamide promotes cellular senescence in a human glioblastoma cell line.

  2024cites this paper
• Permission to pass: on the role of p53 as a gatekeeper for aneuploidy

  2023cites this paper
• Mis-splicing Drives Loss of Function of p53E224D Point Mutation

  2023cites this paper
• Partial p53 reactivation is sufficient to induce cancer regression

  2022cites this paper
• Multiple functions of tumor supressor p53

  2022cites this paper
• A Unique Spectrum of Spontaneous Tumors in Dino Knockout Mice Identifies Tissue-Specific Requirements for Tumor Suppression

  2022cites this paper
• The Genomics of Liposarcoma: A Review and Commentary

  2022cites this paper
• Identification of mutant p53-specific proteins interaction network using TurboID-based proximity labeling.

  2022cites this paper
• Disruption of tp53 leads to cutaneous nevus and melanoma formation in Xenopus tropicalis

  2022cites this paper
• Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?

  2022cites this paper
• The telomere complex and the origin of the cancer stem cell

  2021cites this paper
• Cancer metabolism and tumor microenvironment: fostering each other?

  2021cites this paper
• Rely on Each Other: DNA Binding Cooperativity Shapes p53 Functions in Tumor Suppression and Cancer Therapy

  2021cites this paper
• Mouse Models of Frequently Mutated Genes in Acute Myeloid Leukemia

  2021cites this paper
• p53 partial loss-of-function mutations sensitize to chemotherapy

  2021cites this paper
• Regulation of p53 by E3s

  2021cites this paper
• Biophysical investigation of the dual binding surfaces of human transcription factors FOXO4 and p53

  2021cites this paper
• p53 and Tumor Suppression: It Takes a Network.

  2021cites this paper
• The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient

  2020cites this paper
• Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia

  2020cites this paper
• Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?

  2020cites this paper
• Mutant p53 oncogenicity - dominant-negative or gain-of-function?

  2020cites this paper
• Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis

  2020cites this paper
• Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer

  2020influential citation
• Sphingolipids and the link between alcohol and cancer.

  2020cites this paper
• p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival

  2020cites this paper
• p53 deficiency triggers dysregulation of diverse cellular processes in physiological oxygen

  2020cites this paper
• BRCA1/P53: Two strengths in cancer chemoprevention.

  2020cites this paper
• Rapid generation and selection of Cas9-engineering TRP53 R172P mice that do not have off-target effects

  2019cites this paper
• The non-homologous end-joining activity is required for Fanconi anemia fetal HSC maintenance

  2019cites this paper
• Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation.

  2019cites this paper
• p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms

  2019cites this paper
• An LTR retrotransposon‐derived lncRNA interacts with RNF169 to promote homologous recombination

  2019cites this paper
• p53 defies convention again: a p53 mutant that has lost tumor suppression but still can kill

  2019cites this paper
• B Cell Lymphomagenesis

  2019cites this paper
• Sox2+ cells in Sonic Hedgehog-subtype medulloblastoma resist p53-mediated cell-cycle arrest response and drive therapy-induced recurrence

  2019cites this paper
• Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses

  2019cites this paper
• Identifying functional evolution processes according to the pathological stages of colorectal cancer

  2019cites this paper
• Pathophysiological Functions of the lncRNA TUG1.

  2019cites this paper
• p53‐TP53‐Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells

  2019cites this paper
• Diverse and cancer type-specific roles of the p53 R248Q gain-of-function mutation in cancer migration and invasiveness

  2019cites this paper
• How the Other Half Lives: What p53 Does When It Is Not Being a Transcription Factor

  2019cites this paper
• Restoring p53 in cancer: the promises and the challenges

  2019cites this paper
• p53 orchestrates DNA replication restart homeostasis by suppressing mutagenic RAD52 and POLθ pathways

  2018cites this paper
• 1 The Role of Aneuploidy in Cancer Evolution

  2018cites this paper
• Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation

  2018influential citation
• p 53 suppresses mutagenic RAD 52 and POL pathways by orchestrating DNA 1 replication restart homeostasis 2

  2018cites this paper
• Biocompatible Gold Nanoparticles Ameliorate Retinoic Acid-Induced Cell Death and Induce Differentiation in F9 Teratocarcinoma Stem Cells

  2018cites this paper
• Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review

  2018cites this paper
• How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.

  2018cites this paper
• Gain of function in the mouse model of a recurrent mutation p53N236S promotes the formation of double minute chromosomes and the oncogenic potential of p19ARF

  2018cites this paper
• The transcription and expression profile of p53N236S mutant reveals new aspects of gain of function for mutant p53

  2018cites this paper
• Functional relationship between p53 and RUNX proteins

  2018cites this paper
• The Role of Aneuploidy in Cancer Evolution.

  2017cites this paper
• Deconstructing networks of p53-mediated tumor suppression in vivo

  2017cites this paper
• p53: Multiple Facets of a Rubik's Cube.

  2017cites this paper
• Inherited TP53 Mutations and the Li-Fraumeni Syndrome.

  2017cites this paper
• The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence.

  2017cites this paper
• Inherited TP 53 Mutations and the Li – Fraumeni Syndrome

  2017cites this paper
• p53 suppresses mutagenic RAD52 and POLθ pathways by orchestrating DNA replication restart homeostasis

  2017cites this paper
• Regulation of Metabolic Activity by p53

  2017cites this paper
• Senescence, Apoptosis, and Cancer

  2017cites this paper
• EVALUATING THE THERAPEUTIC EFFICACY OF RESTORING WILD-TYPE P53 ACTIVITY IN P53-MUTANT TUMORS

  2017cites this paper
• Caractérisation de la sénescence des cardiomyocytes et identification de marqueurs associés

  2017cites this paper
• Putting p53 in Context.

  2017cites this paper
• Molecular profile of atypical hyperplasia of the breast

  2017cites this paper
• Senescence in Health and Disease.

  2017cites this paper
• A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo

  2017cites this paper
• Ironing out how p53 regulates ferroptosis

  2016cites this paper
• Dysfunctional telomeres induce p53‐dependent and independent apoptosis to compromise cellular proliferation and inhibit tumor formation

  2016cites this paper
• The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression.

  2016cites this paper
• The Effects of SUMO modification of the Tumour Suppressor p53

  2016cites this paper
• Identifying and Targeting the Cause of Cancer is Needed to Cure Cancer

  2016cites this paper
• STAT5A is regulated by DNA damage via the tumor suppressor p53.

  2016cites this paper
• Genome Stability Requires p53.

  2016cites this paper
• CEP-1 is pro-choice for reproductive health in C. elegans

  2016cites this paper
• ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth

  2016cites this paper
• CD1d-restricted peripheral T cell lymphoma in mice and humans

  2016cites this paper
• The myelodysplastic syndromes

  2016cites this paper
• Lysines in the tetramerization domain of p53 selectively modulate G1 arrest

  2016cites this paper
• CD 1 d-restricted peripheral T cell lymphoma in mice and humans

  2016cites this paper
• Cancer, Oxidative Stress, and Metastasis.

  2016cites this paper
• [Punish or cherish: p53, metabolism and tumor suppression].

  2015cites this paper
• TP53: an oncogene in disguise

  2015cites this paper
• The role of DNA damage responses in p53 biology

  2015cites this paper
• Modeling osteosarcoma: in vitro and in vivo approaches

  2015cites this paper